MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs)

(2018) Adele Vivacqua et al.   Cells

Epidemiology and treatment patterns of epithelial ovarian cancer

(2017) Philip Jessmon et al.   Expert Review of Anticancer Therapy

PARP inhibitors for targeted treatment in ovarian cancer

(2017) Don S Dizon   LANCET

Non-coding RNA: More uses for genomic junk

(2017) Karen Adelman et al.   NATURE

miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions

(2017) Chih-Hung Chou et al.   NUCLEIC ACIDS RESEARCH

Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma

(2016) Tong Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

miRPathDB: a new dictionary on microRNAs and target pathways

(2016) Christina Backes et al.   NUCLEIC ACIDS RESEARCH

dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers

(2016) Zhen Yang et al.   NUCLEIC ACIDS RESEARCH

miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2

(2015) CHUNYAN WEN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

(2015) Junzo Hamanishi et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA-338-3p suppresses tumor growth of esophageal squamous cell carcinoma in vitro and in vivo

(2015) XINYU LI et al.   Molecular Medicine Reports

Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis

(2015) RUITAO ZHANG et al.   ONCOLOGY REPORTS

miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a

(2013) Xin Chen et al.   FEBS LETTERS

miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a

(2013) Bo Guo et al.   MOLECULAR CANCER RESEARCH

DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows

(2013) Maria D. Paraskevopoulou et al.   NUCLEIC ACIDS RESEARCH

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

microRNA involvement in human cancer

(2012) M. V. Iorio et al.   CARCINOGENESIS

The Rectal Cancer microRNAome - microRNA Expression in Rectal Cancer and Matched Normal Mucosa

(2012) J. Gaedcke et al.   CLINICAL CANCER RESEARCH

Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer

(2012) Ruby Yun-Ju Huang et al.   CURRENT DRUG TARGETS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

MACC1 controls Met: What a difference an Sp1 site makes

(2011) Ulrike Stein et al.   CELL CYCLE

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer

(2011) Gottfried E. Konecny et al.   CLINICAL CANCER RESEARCH

Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells

(2011) Ruitao Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence

(2010) Hidehiko Shimokawa et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Small silencing RNAs: an expanding universe

(2009) Megha Ghildiyal et al.   NATURE REVIEWS GENETICS

HGF/MET Signaling in Ovarian Cancer

(2008) Hong Zhou et al.   CURRENT MOLECULAR MEDICINE